Development of a Nuclear Morphometric Signature for Prostate Cancer Risk in Negative Biopsies

被引:12
|
作者
Gann, Peter H. [1 ]
Deaton, Ryan [1 ]
Amatya, Anup [2 ]
Mohnani, Mahesh [1 ]
Rueter, Erika Enk [1 ]
Yang, Yirong [3 ]
Ananthanarayanan, Viju [4 ]
机构
[1] Univ Illinois, Dept Pathol, Chicago, IL 60607 USA
[2] New Mexico State Univ, Dept Publ Hlth Sci, Las Cruces, NM 88003 USA
[3] Univ New Mexico, Coll Pharm, Albuquerque, NM 87131 USA
[4] Univ Chicago, Dept Pathol, Chicago, IL 60637 USA
来源
PLOS ONE | 2013年 / 8卷 / 07期
基金
美国国家卫生研究院;
关键词
IMAGE-ANALYSIS; INTRAEPITHELIAL NEOPLASIA; CHROMATIN TEXTURE; EPITHELIAL-CELLS; FOLLOW-UP; PREDICTS; METASTASIS; RECURRENCE; KARYOMETRY; NUCLEOLAR;
D O I
10.1371/journal.pone.0069457
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
Background: Our objective was to develop and validate a multi-feature nuclear score based on image analysis of direct DNA staining, and to test its association with field effects and subsequent detection of prostate cancer (PCa) in benign biopsies. Methods: Tissue sections from 39 prostatectomies were Feulgen-stained and digitally scanned (4006), providing maps of DNA content per pixel. PCa and benign epithelial nuclei were randomly selected for measurement of 52 basic morphometric features. Logistic regression models discriminating benign from PCa nuclei, and benign from malignant nuclear populations, were built and cross-validated by AUC analysis. Nuclear populations were randomly collected <1 mm or >5 mm from cancer foci, and from cancer-free prostates, HGPIN, and PCa Gleason grade 3-5. Nuclei also were collected from negative biopsy subjects who had a subsequent diagnosis of PCa and age-matched cancer-free controls (20 pairs). Results: A multi-feature nuclear score discriminated cancer from benign cell populations with AUCs of 0.91 and 0.79, respectively, in training and validation sets of patients. In prostatectomy samples, both nuclear-and population-level models revealed cancer-like features in benign nuclei adjacent to PCa, compared to nuclei that were more distant or from PCa-free glands. In negative biopsies, a validated model with 5 variance features yielded significantly higher scores in cases than controls (P = 0.026). Conclusions: A multifeature nuclear morphometric score, obtained by automated digital analysis, was validated for discrimination of benign from cancer nuclei. This score demonstrated field effects in benign epithelial nuclei at varying distance from PCa lesions, and was associated with subsequent PCa detection in negative biopsies. Impact: This nuclear score shows promise as a risk predictor among men with negative biopsies and as an intermediate biomarker in Phase II chemoprevention trials. The results also suggest that subvisual disturbances in nuclear structure precede the development of pre-neoplastic lesions.
引用
收藏
页数:9
相关论文
共 50 条
  • [1] The current value of histological findings in negative prostate biopsies to predict the future risk of clinically significant prostate cancer
    Schwartzmann, I
    Celma, A.
    Regis, L.
    Planas, J.
    Roche, S.
    de Torres, I. M.
    Semidey, M. E.
    Morote, J.
    ACTAS UROLOGICAS ESPANOLAS, 2021, 45 (06): : 447 - 454
  • [2] Race Differences in Telomere Length in Benign Prostate Biopsies and Subsequent Risk of Prostate Cancer
    Rybicki, Benjamin A.
    Sadasivan, Sudha M.
    Chen, Yalei
    Loveless, Ian
    Gupta, Nilesh S.
    Chitale, Dhananjay A.
    Williamson, Sean R.
    Rundle, Andrew G.
    Tang, Deliang L.
    CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION, 2022, 31 (05) : 991 - 998
  • [3] Plasma microRNA signature is associated with risk stratification in prostate cancer patients
    Al-Qatati, Abeer
    Akrong, Christine
    Stevic, Ines
    Pantel, Klaus
    Awe, Julius
    Saranchuk, Jeff
    Drachenberg, Darrel
    Mai, Sabine
    Schwarzenbach, Heidi
    INTERNATIONAL JOURNAL OF CANCER, 2017, 141 (06) : 1231 - 1239
  • [4] Development and Validation of a Novel TP53 Mutation Signature That Predicts Risk of Metastasis in Primary Prostate Cancer
    Chipidza, Fallon E.
    Alshalalfa, Mohammed
    Mahal, Brandon A.
    Karnes, R. Jeffrey
    Liu, Yang
    Davicioni, Elai
    Martin, Neil E.
    Mouw, Kent W.
    Feng, Felix Y.
    Nguyen, Paul L.
    Muralidhar, Vinayak
    CLINICAL GENITOURINARY CANCER, 2021, 19 (03) : 246 - +
  • [5] Mimickers of Prostate Cancer in Needle Biopsies
    Algaba, Ferran
    Trias, Isabel
    ANALYTICAL AND QUANTITATIVE CYTOPATHOLOGY AND HISTOPATHOLOGY, 2015, 37 (01): : 57 - 64
  • [6] Calcium and Nuclear Signaling in Prostate Cancer
    Maly, Ivan V.
    Hofmann, Wilma A.
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2018, 19 (04)
  • [7] Development and Validation of a 28-gene Hypoxia-related Prognostic Signature for Localized Prostate Cancer
    Yang, Lingjian
    Roberts, Darren
    Takhar, Mandeep
    Erho, Nicholas
    Bibby, Becky A. S.
    Thiruthaneeswaran, Niluja
    Bhandari, Vinayak
    Cheng, Wei-Chen
    Haider, Syed
    McCorry, Amy M. B.
    McArt, Darragh
    Jain, Suneil
    Alshalalfa, Mohammed
    Ross, Ashley
    Schaffer, Edward
    Den, Robert B.
    Karnes, R. Jeffrey
    Klein, Eric
    Hoskin, Peter J.
    Freedland, Stephen J.
    Lamb, Alastair D.
    Neal, David E.
    Buffa, Francesca M.
    Bristow, Robert G.
    Boutros, Paul C.
    Davicioni, Elai
    Choudhury, Ananya
    West, Catharine M. L.
    EBIOMEDICINE, 2018, 31 : 182 - 189
  • [8] Evaluation of Matrix Metalloproteases by Artificial Intelligence Techniques in Negative Biopsies as New Diagnostic Strategy in Prostate Cancer
    Eiro, Noemi
    Medina, Antonio
    Gonzalez, Luis O.
    Fraile, Maria
    Palacios, Ana
    Escaf, Safwan
    Fernandez-Gomez, Jesus M.
    Vizoso, Francisco J.
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2023, 24 (08)
  • [9] Prostate Cancer Detected by Methylated Gene Markers in Histopathologically Cancer-Negative Tissues from Men with Subsequent Positive Biopsies
    Troyer, Dean A.
    Lucia, M. Scott
    de Bruine, Adriann P.
    Mendez-Meza, Rosario
    Baldewijns, Marcella M.
    Dunscomb, Nancy
    Van Engeland, Manon
    McAskill, Theresa
    Bierau, Katja
    Louwagie, Joost
    Bigley, Joseph W.
    CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION, 2009, 18 (10) : 2717 - 2722
  • [10] A morphometric signature to identify ductal carcinoma in situ with a low risk of progression
    Sobral-Leite, Marcelo
    Castillo, Simon P.
    Vonk, Shiva
    Messal, Hendrik A.
    Melillo, Xenia
    Lam, Noomie
    de Bruijn, Brandi
    Hagos, Yeman B.
    van den Bos, Myrna
    Sanders, Joyce
    Almekinders, Mathilde
    Visser, Lindy L.
    Groen, Emma J.
    Kristel, Petra
    Ercan, Caner
    Azarang, Leyla
    van Rheenen, Jacco
    Hwang, E. Shelley
    Yuan, Yinyin
    Menezes, Renee
    Lips, Esther H.
    Wesseling, Jelle
    NPJ PRECISION ONCOLOGY, 2025, 9 (01)